Anti-tumor response induced by immunologically modified carbon nanotubes and laser irradiation using rat mammary tumor model

Joseph T. Acquaviva III; Cody F. Bahavar; Feifan Zhou; Xiaosong Li; Eric W. Howard; Liz C. Bullen; Ricardo P. Silvy; Wei R. Chen

doi:10.1142/s1793545815500364

[1] D. M. Pardoll, S. L. Topalian, "The role of CD4 T cell responses in antitumor immunity," Curr. Opin. Immunol. 10(5), 588–594 (1998).

[2] A. Porgador, D. Snyder, E. Gilboa, "Induction of antitumor immunity using bone marrow-generated dendritic cells," J. Immunol. 156(8), 2918–2926 (1996).

[3] W. R. Chen, W. Zhu, J. R. Dynlacht, H. Liu, R. E. Nordquist, "Long-term tumor resistance induced by laser photo-immunotherapy," Int. J. Cancer 81(5), 808–812 (1999).

[4] W. R. Chen, R. Carubelli, H. Liu, R. E. Nordquist, "Laser immunotherapy," Mol. Biotechnol. 25(1), 37–43 (2003).

[5] J. O. Funk, A. Kruse, H. Kirchner, "Cytokine production after helium neon laser irradiation in cultures of human peripheral blood mononuclear cells," Photochem. Photobiol. B Biol. 16(3), 347–355 (1992).

[6] S. Song, F. Zhou, R. E. Nordquist, R. Carubelli, H. Lui, W. R. Chen, "Glycated chitosan as a new non-toxic immunological stimulant," Immunopharmacol. Immunotoxicol. 31(2), 202–208 (2009).

[7] F. Zhou, X. Li, S. Song, J. T. Acquaviva III, R. F. Wolf, E. W. Howard, W. R. Chen, "Anti-tumor responses induced by laser irradiation and immunological stimulation using a mouse mammary tumor model," J. Innov. Opt. Health Sci. 6(04), 1350039 (2013).

[8] W. R. Chen, H. Liu, J. A. Nordquist and R. E. Nordquist, "Tumour cell damage and leucocyte in- filtration after laser immunotherapy treatment," Lasers Med. Sci. 15(1), 43–48 (2000).

[9] L. Xiaosong, G. L. Ferrel, M. C. Guerra, T. Hode, J. A. Lunn, O. Adalsteinsson, R. E. Nordquist, H. Liu, W. R. Chen, "Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients," Photochem. Photobiol. Sci. 10(5), 817–821 (2011).

[10] A. Bianco, K. Kostarelos and M. Prato, "Applications of carbon nanotubes in drug delivery," Curr. Opin. Chem. Biol. 9(6), 674–679 (2005).

[11] S. M. Bachilo, M. S. Strano, C. Kittrell, R. H. Hauge, R. E. Smalley, B. R. Weisman, "Structureassigned optical spectra of single-walled carbon nanotubes," Science 298(5602), 2361–2366 (2002).

[12] F. Zhou, D. Xing, B. Wu, S. Wu, Z. Ou, W. R. Chen, "New insights of transmembranal mechanism and subcellular localization of noncovalently modi- fied single-walled carbon nanotubes," Nano Lett. 10(5), 1677–1681 (2010).

[13] B. Kitiyanan, W. E. Alvarez, J. H. Harwell, D. E. Resasco, "Controlled production of single-wall carbon nanotubes by catalytic decomposition of CO on bimetallic Co–Mo catalysts," Chem. Phys. Lett. 317, 497–503 (2000).

[14] S. M. Bachilo, L. Balzano, J. E. Herrera, F. Pompeo, D. E. Resasco, R. B. Weisman, "Narrow (n;m)-distribution of single-walled carbon nanotubes grown using a solid supported catalyst," J. Am. Chem. Soc. 125, 11186–11187 (2003).

[15] G. Lolli, L. Zhang, L. Balzano, N. Sakulchaicharoen, Y. Tan, D. E. Resasco, "Tailoring (n,m) structure of single-walled carbon nanotubes by modifying reaction conditions and the nature of the support of CoMo," Catal. J. Phys. Chem. B 110, 2108–2115 (2006).

[16] C. A. Bailey, T. M. Cowan,V.G. Liu, E. C. Lemley,W. R. Chen, "Optimization of selective hyperthermia," Biomed. Opt. 9(3), 648–654 (2004).

[17] M. B. Vrouenraets, G. W. M. Visser, G. B. Snow, V. Dongen, "Basic principles, applications in oncology and improved selectivity of photodynamic therapy," Anticancer Res. 23, 505–522 (2003).

[18] W. R. Chen, S. W.Jeong, M. D. Lucroy, R. F. Wolf,E. W. Howard, H. Liu, R. E. Nordquist, "Induced antitumor immunity against DMBA-4 metastatic mammary tumors in rats using laser immunotherapy," Int. J. Cancer 107(6), 1053–1057 (2003).

[19] H. Udono, P. K. Srivastava, "Heat shock protein 70- associated peptides elicit specific cancer immunity," J. Exp. Med. 178(4), 1391–1396 (1993).

[20] S. Janetzki, D. Palla, V. Rosenhauer, H. Lochs, J. J. Lewis, P. K. Srivastava, "Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: A pilot study," Int. J. Cancer 88(2), 232–238 (2000).

[21] S. Basu, R. J. Binder, R. Suto, K. M. Anderson, P. K. Srivastava, "Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kB pathway," J. Immunol. 12(11), 1539–1546 (2000).

[22] A. Melcher, S. Todryk, N. Hardwick, M. Ford, M. Jacobson, R. G. Vile, "Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression," Nat. Med. 4(5), 581–587 (1998).